87
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Pain in femoral arteriography
A double-blind, randomized, clinical study comparing safety and efficacy of the iso-osmolar iodixanol 270 mgI/ml and the low-osmolar iomeprol 300 mgI/ml in 9 European centers

, , , , &
Pages 590-596 | Published online: 09 Jul 2009

References

  • American College of Radiology Committee on Drugs and Contrast Media. Manual on Iodinated Contrast Media. 4.1 edn. Reston: American College of Radiology, 1991.
  • Dawson P. The non-ionic dimers — some theoretical and clinical considerations. Eur. Radiol. 1995; 5: 103–6.
  • Eivindvik K, Sjogren CE. Physiochemical properties of Iodixanol. Acta Radiol. 1995; 399 (Suppl): 32–8.
  • Fischbach RM, Landwehr P, Ernst SU, Heindel WL, Bongers A, Lackner K. Automated stepping DSA versus standard DSA technique for the examination of lower extre-mity arterial occlusive disease. Radiology 1997; 205: 464.
  • Galloti A, Uggeri F, Favilla A, Cabrini M, Hadn C. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations. Eur. J. Radiol. 1994; 18: S1–12.
  • Grainger R. Dawson P. Guidelines for the Use of Low Osmolar Intravascular Contrast Agents. London: Royal College of Radiologists, 1991.
  • Holder JC, Dalrymple GV. Pain and aorto femoral arter-iography: the importance of chemical structure and osmol-ality of contrast agents. Invest. Radiol. 1981; 16: 508–12.
  • Justesen P, Downes M, Grynne BH, Lang H, Rasch W, Seim E. Injection-associated pain in femoral arteriography. A European multicentre study comparing safety, tolerabil-ity and efficacy of iodixanol and iopromide. Cardiovasc Intervent. Radiol. 1997; 20: 251–6.
  • Klow NE, Levorstad K, Berg KJ, et al. Iodixanol in cardioan-giography in patients with coronary artery disease. Tolerability, cardiac and renal effects. Acta Radiol. 1993; 34: 72–7.
  • MacLennan AC, Machan LS. A comparative, randomised, double-blind, cross-over trial of iodixanol 270 and iohexol 300 in femoral arteriography. CIRSE 1997; 167: 89.
  • Manninen H, Tahvanainen K, Borch K, et al. Iodixanol, a new non-ionic, dimeric contrast medium in cardioangio-graphy: a double-blind, parallel comparison with iopromide. Eur. Radiol. 1995; 5: 364–70.
  • Nossen JO, Bach-Gansmo T, Kloster Y, Jorgensen NJ. Heat sensation in connection with intravenous injection of isotonic and low-osmolar X-ray contrast media and manni-tol solutions. Eur. Radiol. 1993; 3: 46–8.
  • Padayachee TS, Reidy JF, King DH, Reeves M, Gosling RG. Femoral artery flow and pain during lumbar aortography; comparison of ionic and non-ionic contrast media. Clin. Radiol. 1983; 34: 79–85.
  • Palmers Y, De Greef D, Grynne BH, Smits J, Put E. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mg I/m1 and ioxaglate 320 mg I/m1 in cerebral arteriography. Eur. J. Radiol. 1993; 17: 203–9.
  • Pugh ND, Sissons GRJ, Ruttley MST, Berg KJ, Nossen JO, Eide H. Iodixanol in femoral arteriography (phase III). A comparative double-blind parallel trial between iodixanol and iopromide. Clin. Radiol. 1993; 47: 96–9.
  • Schmiedel E. Evaluation of contrast density of iomeprol. Eur. J. Radiol. 1994; 18: S97–103.
  • Sutton AGC, Finn P, Grech ED, Hall JA, et al. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am. Heart J. 2001; 141: 677–83.
  • Thorstensen O, Albrechtsson U, Calissendorff B, et al. Iodixanol in femoral arteriography. A randomized, double-blind, phase III, parallels study with iodixanol 270 mg I/m1 and iohexol 300 mg I/ml. Acta Radiol. 1994; 35: 629–35.
  • Ugolotti U, Larini P, Marcato C, Cusmano F, Puccianti F. Peripheral arteriography with a new non-ionic agent. com-parison of iomeprol with iopamidol. Eur. J. Radiol. 1994; 18: S77–82.
  • Verow P, Nossen JO, Sheppick A, Kjwrsgaard P. A comparison of iodixanol with iopamidol in aorto-femoral angiography. Br. J. Radiol. 1995; 68: 973–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.